The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation

Research output: Contribution to journal › Article › peer-review

BRAF V600E mutation, Integrins, Osteopontin, Thyroid cancer, NODULES, CANCER, NEEDLE-ASPIRATION-CYTOLOGY, Prognosis, Follow-Up Studies, Humans, Osteopontin/genetics, Proto-Oncogene Proteins B-raf/genetics, Case-Control Studies, Thyroid Neoplasms/genetics, Biomarkers, Tumor/genetics, Integrins/genetics, Neoplasm Metastasis, Mutation, Carcinoma, Papillary/genetics

ID: 17118611